Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 1, no: 15 |
NetGPI | no | yes: 0, no: 16 |
Term | Name | Level | Count |
---|---|---|---|
GO:0016020 | membrane | 2 | 13 |
GO:0110165 | cellular anatomical entity | 1 | 13 |
GO:0031207 | Sec62/Sec63 complex | 3 | 1 |
GO:0032991 | protein-containing complex | 1 | 1 |
GO:0098796 | membrane protein complex | 2 | 1 |
GO:0140534 | endoplasmic reticulum protein-containing complex | 2 | 1 |
Related structures:
AlphaFold database: A4HJV4
Term | Name | Level | Count |
---|---|---|---|
GO:0006605 | protein targeting | 5 | 1 |
GO:0006612 | protein targeting to membrane | 5 | 1 |
GO:0006613 | cotranslational protein targeting to membrane | 6 | 1 |
GO:0006614 | SRP-dependent cotranslational protein targeting to membrane | 7 | 1 |
GO:0006620 | post-translational protein targeting to endoplasmic reticulum membrane | 6 | 1 |
GO:0006810 | transport | 3 | 1 |
GO:0006886 | intracellular protein transport | 4 | 1 |
GO:0008104 | protein localization | 4 | 1 |
GO:0009987 | cellular process | 1 | 1 |
GO:0015031 | protein transport | 4 | 1 |
GO:0033036 | macromolecule localization | 2 | 1 |
GO:0033365 | protein localization to organelle | 5 | 1 |
GO:0045047 | protein targeting to ER | 6 | 1 |
GO:0045184 | establishment of protein localization | 3 | 1 |
GO:0046907 | intracellular transport | 3 | 1 |
GO:0051179 | localization | 1 | 1 |
GO:0051234 | establishment of localization | 2 | 1 |
GO:0051641 | cellular localization | 2 | 1 |
GO:0051649 | establishment of localization in cell | 3 | 1 |
GO:0051668 | localization within membrane | 3 | 1 |
GO:0070727 | cellular macromolecule localization | 3 | 1 |
GO:0070972 | protein localization to endoplasmic reticulum | 6 | 1 |
GO:0071702 | organic substance transport | 4 | 1 |
GO:0071705 | nitrogen compound transport | 4 | 1 |
GO:0072594 | establishment of protein localization to organelle | 4 | 1 |
GO:0072599 | establishment of protein localization to endoplasmic reticulum | 5 | 1 |
GO:0072657 | protein localization to membrane | 4 | 1 |
GO:0090150 | establishment of protein localization to membrane | 4 | 1 |
Term | Name | Level | Count |
---|---|---|---|
GO:0005215 | transporter activity | 1 | 1 |
GO:0008320 | protein transmembrane transporter activity | 3 | 1 |
GO:0022857 | transmembrane transporter activity | 2 | 1 |
GO:0022884 | macromolecule transmembrane transporter activity | 3 | 1 |
GO:0140318 | protein transporter activity | 2 | 1 |
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_C14_Caspase3-7 | 106 | 110 | PF00656 | 0.445 |
CLV_C14_Caspase3-7 | 157 | 161 | PF00656 | 0.763 |
CLV_MEL_PAP_1 | 131 | 137 | PF00089 | 0.430 |
CLV_NRD_NRD_1 | 6 | 8 | PF00675 | 0.727 |
CLV_NRD_NRD_1 | 96 | 98 | PF00675 | 0.595 |
CLV_PCSK_KEX2_1 | 35 | 37 | PF00082 | 0.481 |
CLV_PCSK_KEX2_1 | 6 | 8 | PF00082 | 0.727 |
CLV_PCSK_KEX2_1 | 95 | 97 | PF00082 | 0.632 |
CLV_PCSK_PC1ET2_1 | 35 | 37 | PF00082 | 0.471 |
CLV_PCSK_PC1ET2_1 | 95 | 97 | PF00082 | 0.561 |
CLV_PCSK_SKI1_1 | 40 | 44 | PF00082 | 0.486 |
CLV_PCSK_SKI1_1 | 6 | 10 | PF00082 | 0.718 |
DEG_SPOP_SBC_1 | 104 | 108 | PF00917 | 0.487 |
DOC_MAPK_gen_1 | 35 | 43 | PF00069 | 0.293 |
DOC_MAPK_MEF2A_6 | 36 | 45 | PF00069 | 0.293 |
DOC_MAPK_RevD_3 | 131 | 145 | PF00069 | 0.201 |
DOC_PP1_RVXF_1 | 116 | 123 | PF00149 | 0.300 |
DOC_PP4_FxxP_1 | 139 | 142 | PF00568 | 0.619 |
DOC_USP7_MATH_1 | 164 | 168 | PF00917 | 0.617 |
DOC_USP7_MATH_1 | 27 | 31 | PF00917 | 0.365 |
DOC_USP7_UBL2_3 | 31 | 35 | PF12436 | 0.298 |
DOC_WW_Pin1_4 | 23 | 28 | PF00397 | 0.281 |
LIG_14-3-3_CanoR_1 | 134 | 138 | PF00244 | 0.361 |
LIG_BRCT_BRCA1_1 | 135 | 139 | PF00533 | 0.350 |
LIG_BRCT_BRCA1_1 | 54 | 58 | PF00533 | 0.271 |
LIG_LIR_Apic_2 | 136 | 142 | PF02991 | 0.430 |
LIG_LIR_Gen_1 | 116 | 125 | PF02991 | 0.298 |
LIG_LIR_Gen_1 | 55 | 65 | PF02991 | 0.272 |
LIG_LIR_Nem_3 | 116 | 122 | PF02991 | 0.424 |
LIG_LIR_Nem_3 | 136 | 141 | PF02991 | 0.365 |
LIG_LIR_Nem_3 | 18 | 23 | PF02991 | 0.264 |
LIG_LIR_Nem_3 | 196 | 202 | PF02991 | 0.656 |
LIG_LIR_Nem_3 | 55 | 61 | PF02991 | 0.277 |
LIG_LIR_Nem_3 | 63 | 68 | PF02991 | 0.291 |
LIG_MLH1_MIPbox_1 | 135 | 139 | PF16413 | 0.327 |
LIG_Pex14_2 | 128 | 132 | PF04695 | 0.398 |
LIG_SH2_CRK | 20 | 24 | PF00017 | 0.293 |
LIG_SH2_CRK | 38 | 42 | PF00017 | 0.293 |
LIG_SH2_NCK_1 | 101 | 105 | PF00017 | 0.466 |
LIG_SH2_STAT5 | 111 | 114 | PF00017 | 0.445 |
LIG_SH2_STAT5 | 119 | 122 | PF00017 | 0.248 |
LIG_SH2_STAT5 | 99 | 102 | PF00017 | 0.474 |
LIG_SH3_2 | 16 | 21 | PF14604 | 0.293 |
LIG_SH3_3 | 13 | 19 | PF00018 | 0.407 |
LIG_TRAF2_1 | 154 | 157 | PF00917 | 0.595 |
LIG_TRAF2_1 | 193 | 196 | PF00917 | 0.658 |
LIG_TRAF2_1 | 30 | 33 | PF00917 | 0.271 |
LIG_UBA3_1 | 137 | 145 | PF00899 | 0.586 |
LIG_WRC_WIRS_1 | 165 | 170 | PF05994 | 0.463 |
MOD_CK1_1 | 113 | 119 | PF00069 | 0.546 |
MOD_CK1_1 | 159 | 165 | PF00069 | 0.553 |
MOD_CK2_1 | 27 | 33 | PF00069 | 0.321 |
MOD_CK2_1 | 46 | 52 | PF00069 | 0.243 |
MOD_GlcNHglycan | 112 | 115 | PF01048 | 0.622 |
MOD_GlcNHglycan | 151 | 154 | PF01048 | 0.565 |
MOD_GlcNHglycan | 183 | 186 | PF01048 | 0.630 |
MOD_GlcNHglycan | 187 | 190 | PF01048 | 0.630 |
MOD_GlcNHglycan | 48 | 51 | PF01048 | 0.430 |
MOD_GlcNHglycan | 86 | 89 | PF01048 | 0.628 |
MOD_GSK3_1 | 171 | 178 | PF00069 | 0.496 |
MOD_GSK3_1 | 181 | 188 | PF00069 | 0.461 |
MOD_GSK3_1 | 23 | 30 | PF00069 | 0.255 |
MOD_N-GLC_1 | 203 | 208 | PF02516 | 0.449 |
MOD_PK_1 | 187 | 193 | PF00069 | 0.609 |
MOD_PKA_2 | 133 | 139 | PF00069 | 0.361 |
MOD_PKA_2 | 2 | 8 | PF00069 | 0.615 |
MOD_Plk_1 | 171 | 177 | PF00069 | 0.548 |
MOD_Plk_4 | 133 | 139 | PF00069 | 0.408 |
MOD_ProDKin_1 | 23 | 29 | PF00069 | 0.329 |
MOD_SUMO_rev_2 | 194 | 202 | PF00179 | 0.576 |
MOD_SUMO_rev_2 | 30 | 37 | PF00179 | 0.356 |
TRG_DiLeu_BaLyEn_6 | 4 | 9 | PF01217 | 0.652 |
TRG_ENDOCYTIC_2 | 119 | 122 | PF00928 | 0.430 |
TRG_ENDOCYTIC_2 | 199 | 202 | PF00928 | 0.637 |
TRG_ENDOCYTIC_2 | 20 | 23 | PF00928 | 0.346 |
TRG_ENDOCYTIC_2 | 38 | 41 | PF00928 | 0.353 |
TRG_ENDOCYTIC_2 | 65 | 68 | PF00928 | 0.380 |
TRG_ER_diArg_1 | 6 | 8 | PF00400 | 0.715 |
TRG_ER_diArg_1 | 96 | 98 | PF00400 | 0.445 |
TRG_NLS_MonoExtN_4 | 94 | 99 | PF00514 | 0.622 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N1IIQ1 | Leptomonas seymouri | 62% | 100% |
A0A0N1PA62 | Leptomonas seymouri | 27% | 89% |
A0A0S4IP06 | Bodo saltans | 38% | 96% |
A0A0S4JTE9 | Bodo saltans | 28% | 76% |
A0A3Q8IAY4 | Leishmania donovani | 28% | 89% |
A0A3R7M6A3 | Trypanosoma rangeli | 29% | 92% |
A0A3S7X515 | Leishmania donovani | 76% | 100% |
A4H9D7 | Leishmania braziliensis | 28% | 100% |
A4HXQ8 | Leishmania infantum | 28% | 89% |
A4I7B6 | Leishmania infantum | 76% | 100% |
C9ZWJ1 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 46% | 94% |
E9ARH0 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 27% | 89% |
E9B2A9 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 76% | 100% |
Q4Q5U7 | Leishmania major | 76% | 100% |
Q4QE09 | Leishmania major | 28% | 100% |